MMP9 and pulmonary emphysema: Recent studies have shown that CS exposure leads to increased levels of MMP9 in the sputum and plasma of patients, resulting in the development of emphysema and decreased FEV1, carbon monoxide diffusion capacity, and oxygen saturation during COPD exacerbation [70,71].